CFV-induced leukemia by subleukemogenic doses of RFV could be correlated with this helper activity suggested that the regressability of RFV-induced leukemia might be a function of its helper (MuLV) component.
In this report, we present evidence that demonstrates that the helper MuLV in RFV is responsible for the regression of RFV-induced leukemia.
Materials and Methods
Vzruses. Cell-free virus stocks were prepared from spleens of leukemic mice (20% wt/vol in phosphate-buffered sahne [PBS]) as previously described (16) and stored in sealed ampules at -70°C RFV and CFV were maintained by serial passage m randombred Swiss/ICR and NIH/ Swiss mice, respectively. N-tropic FV (FV-N), B-tropic FV (FV-B), and N and NB-tropic MuLV-F helper viruses were generously supplied by Dr. R. J. Eckner, Boston University Medical School, Boston, Mass. FV-N and N-tropic MuLV-F were maintained by passage in inbred N/PLCR Fv-l" adult and newborn mice, respectively FV-B and NB-tropic MuLV-F were maintained by passage in adult and newborn BALB/c Fv-1 ~ mice, respectively. The MuLV helper component of FV-B is Btropic Tennant MuLV (17) . NB-tropic MuLV-F was derived by serial passage of N-tropic MuLV-F in newborn BALB/c FV-1 b mice (Dr R. J Eckner, personal communication) NB-tropic Friend virus complex (FV-NB) was generously supplied by Dr P. J. Dawson, Umversity of Oregon Health Sciences Center, Portland, Oreg and was maintained by passage in adult BALB/c FV-1 b mice. MuLV-RF was derived from RFV by dilution passage m Swlss/ICR mice and was maintained by passage in newborn Swiss/ICR.
Mice. Randombred Swiss/ICR and inbred BALB/c mice were from our own colony. Randombred NIH Swms and inbred N/PLCR mine were obtained through the courtesy of the Veterinary Resources Branch, D~vislon of Research Servmes, National Institutes of Health and subsequently bred in our own laboratory Mice were checked biweekly for leukemia and regresmon by spleen palpation We have previously shown that spleen weight determined by palpation is an accurate indicator of leukemic status (4, 9, 16) .
Cell Culture
Mouse embryo fibroblast cultures were prepared from trypsinized 11-to 13-dayold embryos and grown m Dulbecco's modified Eagle's medmm containing 15% calf serum.
Virus Tltratmn. The XC plaque assay (18) was done in 16-mm multiwell tmsue culture trays (Costar, Cambridge, Mass.) using six wells/virus dilution in a manner similar to that described by Croker et al (19) Titers were calculated as either 50% infectious end points for XC plaque formation and expressed in IDso/ml or from the number of individual plaques and expressed in plaque-forming units (PFU)/ml. All wrus t~ters are the mean of at least three determinations.
The spleen focus assay was done as described by Axelrad and Steeves (20) , except that mice were inoculated 1 v. with 0.2 ml of virus suspension. Virus tlters were calculated from the mean number of superficial macroscopic foci per spleen after fixation in Bouin's fluid and are expressed in focus-forming umts (FFU)/ml.
The helper virus assay was done as described by Steeves et al. (15) . N/PLCR Fv-l" mice were inoculated i.v with a constant dilution of FV-B mixed with an equal volume of potential helper MuLV. Virus titers were obtained in helper units (HU) by subtracting the FFU tlter of FV-B alone from that obtained with the virus mixture. One HU is defined as that amount of helper MuLV which increases the titer of SFFV by one FFU.
V~rus Pseudotypes. MuLV-F pseudotypes of SFFV were prepared using the helper wrus assay except that foci were counted on only half of the spleen while the other half was weighed and homogenized in a volume of PBS to give a 10% wt/vol suspension. The suspension was centrifuged to remove cells, and 0.2 ml of a 1.2 or 1:4 dilutmn of the supernate was inoculated LV. into N/PLCR Fv-l" mice Enlarged spleens from mice with erythroleukemia were used to prepare cell-free pseudotype virus stocks (20% wt/vol in PBS) as described above.
Results
Tropism of RFV and CFV. Our previous experiments (11) suggested that the regressability of RFV-induced leukemia might be due to the helper (MuLV) component of the complex. Since the tropism of FV is conferred by its helper virus, we determined the tropism of RFV and CFV by analysis of the doseresponse patterns for formation of spleen foci in mice which differed at the Fv-1 gene locus. Fig. 1 illustrates the dose-response curves for RFV and CFV, compared with those obtained using control N, B, or NB-tropic viruses.
Alleles of the mouse Fv-1 gene restrict the ability of MuLV-F to help SFFV form spleen foci. N-tropic FV is restricted by the Fv-1 b allele, B-tropic FV by the Fv-1" allele. NB-tropic virus is not sensitive to restriction by either allele of Fv-1 (21) . This effect of Fv-1 on the formation of spleen foci is indicated by an apparent decrease in virus titer and/or an increase in the slope of the doseresponse curve (12, 17, 22) .
The estimated titer of RFV was proportional to virus dose at each dilution which gave countable numbers of foci. This pattern is the same as that seen with control FV-NB, suggesting that RFV is NB-tropic. All N or B-tropic FV's assayed in Fv-1 incompatible mice were restricted in their ability to form spleen foci as measured by both final titer and the slope of their dose-response curves. The dose-response pattern caused by CFV is decreased at its SFFV dilution end point in Fv-1 ~ but not in Fv-l" mice, suggesting that its helper MuLV is Ntropic.
We confirmed the tropism of RFV and CFV by XC plaque assay (Table I) . NBtropic RFV produced XC plaques equally well regardless of the Fv-1 Type of Swiss/ICR Mice. Stocks of RFV are regularly obtained by passage through Swiss/ICR mice in which regression has been extensively characterized (3, 4) and which serve as our standard regressor mouse strain. When we attempted to determine their Fv-1 genotype by XC plaque test, we observed that only FV-NB caused XC plaques in embryo cell pools derived from these Swiss/ICR mice. On occasion, plaques did appear after infection with FV-N or FV-B, but their numbers were not proportional to virus dilution. This suggested that Swiss/ICR mice might be heterozygous at the Fv-1 gene locus. To test this possibility, we determined the Fv-1 type of individual Swiss/ICR embryos in XC plaque test using control N, B, or NB-tropic FV's. In preliminary experiments, with cells of known Fv-1 type, we determined the dose of FV-N or FV-B which gave confluent XC plaques in compatible, and no XC plaques in Fv-1 incompatible cells. Cells from each embryo were infected in duplicate with each virus and scored for the presence or absence of XC plaques. The data are summarized in Table II To confirm their Fv-1 genotype, Swiss/ICR mice were inoculated with the control FV's and observed for leukemia development (Table III) . Each of the mouse strains of known Fv-1 type showed the expected incidence of leukemia. The pattern of leukemia incidence in Swiss/ICR suggested that these mice were heterozygous at the Fv-1 gene locus. NB-tropic RFV was infectious for all of the mouse strains tested. N-tropic CFV was also infectious for all of the mouse types due to the high virus dose used and the degree to which CFV demonstrates N tropism as seen in XC or spleen focus titration (see above). These mice were also observed for regression. Leukemia regressed in only those animals infected with NB-tropic RFV or in Swiss/ICR mice infected with FV-NB. Leukemia did not regress in BALB/c mice in accord with our previous results (23) . Effect of Passage of CFV ~n Swiss/ICR M~ce. The tropism of FV can be changed by forced passage in mice that possess at least one Fv-1 incompatible allele (17, 22) . We determined whether passage of CFV in Swiss/ICR would change its tropism and whether this would result in a virus strain which causes a regressing leukemia. After one passage in Swiss/ICR mice, the previously Ntropic CFV became NB-tropic (Table IV) and induced a leukemia that subsequently regressed. A second passage in Swiss/ICR still yielded regression and NB-tropic virus. After this second passage in Swiss/ICR mice, the virus was passaged back through NIH/Swiss mice (Fv-l"") and after five passages the virus remained NB-tropic, as determined by XC test, and the leukemia that it induced retained its ability to spontaneously regress.
Effect of Ri-MuLV on Regression. Since the regressing and nonregressing virus differ in their MuLV component, we determined whether altering the quantity or type of MuLV in RFV would affect regression. For this purpose we used various doses of Ri-MuLV (16) mixed with a constant dose of RFV (Table  V) . In experiment I, a 500-fold excess of Ri-MuLV caused a marked decrease in ~t Ri-MuLV PFU/RFV FFU. ¶ RFV was mixed with a dilution of NLT which was the same as the dilution of Ri-MuLV stock virus whmh gave RffMuLV PFU/RFV FFU equal to 500.
the incidence of regression. Normal lymphoid tissue homogenate or a 20-fold lower dose of Ri-MuLV did not affect regression. In experiment II, in which we used a 10-fold lower dose of RFV, increasing amounts of Ri-MuLV caused a proportional decrease in leukemia regressions and an increase in the incidence of leukemia.
Isolation and Properties of MuLV-RF.
To examine the properties of the MuLV component of RFV associated with leukemia regression, we isolated the helper MuLV from the RFV complex. Helper MuLV's have been obtained from FV by sequential passage in rats or in genetically resistant mice or by end point dilution passage in susceptible mice (13, 24, 25) . To avoid possible changes in virus genetic information or in tropism due to passage in heterologous hosts or resistant mice (26, 22) , we employed end point dilution passage to isolate helper MuLV's from FV. Adult Swiss/ICR mice were infected with 10-fold dilutions of RFV and observed for leukemia development. 2 of 10 mice infected with a 103 dilution of RFV developed erythroleukemia within 14 days post-virus inoculation. At 90 days post-inoculation, one mouse that had previously been negative developed splenomegaly with enlarged lymph nodes and thymus. Examination of histologic sections of lymph nodes, thymus, and spleen showed lymphoblast proliferation in each of these organs and was indicative of lymphocytic leukemia. Lymph node and thymic tissue were used to begin a virus passage line in newborn Swiss/ICR mice. Within 3-5 too, the mice developed splenomegaly with or without gross signs of thymus and lymph node involvement. At 229 days postinoculation, the six mice still alive had enlarged spleens (710-3,250 mg) and lymph nodes, and one of these animals had an enlarged thymus (325 mg). Histopathologic examination of leukemic tissue from these mice confirmed that each had developed lymphocytic leukemia.
The lymphocytic leukemia-inducing component isolated from RFV, MuLV-RF, contains no SFFV activity as determined by spleen focus assay (Table VI) . This virus, like the parental RFV, is NB-tropic by XC plaque assays. It is known that MuLV derived from FV can help defective SFFV's make spleen foci in genetically restrictive mice ~15). MuLV titers are measured in HU and NBtropic MuLV-RF contained at least 104 HU of activity for the SFFV in FV-B as determined in N/PLCR Fv-1" mice. Additional characteristics of MuLV-RF and the leukemia induced by it will be described in a future report. It is of interest to note that the lymphocytic leukemia caused by MuLV-RF itself spontaneously regresses.
The effect of MuLV-RF on nonregressing, CFV leukemia is shown in Table  VII . MuLV-RF, when mixed with CFV and inoculated into adult Swiss/ICR mice, caused the regression of CFV-induced erythroleukemia.
Preparation and Properties of MuLV/RF Pseudotypes of SFFV.
We determined the specificity of the effect of MuLV-RF on nonregressing erythroleukemia by preparing several MuLV pseudotypes of SFFV and testing their ability to induce leukemia that would regress. Pseudotype preparation was accomplished by modification of the helper virus assay in N/PLCR Fv-1 ..... mice. The SFFV in FV-B was rescued by NB or N-tropic helper MuLV-F (Table VIII) . FV-B alone at a 1:40 dilution caused few spleen foci; each of the helper MuLV's used lacked detectable SFFV and therefore could not induce spleen foci. One half of each spleen from mice inoculated with FV-B alone or FV-B plus helper MuLV was used to prepare a 10% wt/vol cell-free extract which was inoculated into susceptible Fv-1 ..... mice to prepare stocks of pseudotype virus (Table IX) .
The extracts prepared from spleens of mice inoculated with both viruses readily induced erythroleukemia within 10 days post-inoculation. In contrast, the spleen extract from mice inoculated with FV-B alone did not cause erythroleukemia, even after a 180-day observation period. To confirm that FV pseudotypes had actually been prepared, the tropism of each of the virus stocks obtained from leukemic mice in Table IX was determined by XC plaque assay. In each case, the original FV-B had acquired the tropism of the helper MuLV used in rescue. Swiss/ICR mice were inoculated with each of the pseudotype virus preparations and observed for leukemia development and regression (Table IX) . SFFV rescued by MuLV-RF caused erythroleukemia, and in 55% of the leukemic mice the disease spontaneously regressed. A lower incidence of regression occurred in mice given the other NB-tropic pseudotype, while regression did not occur at all in mice inoculated with SFFV rescued by N-tropic MuLV-F. RFV differs from conventional strains of FV in tropism, a property controlled by the helper MuLV in the virus complex. FV can be induced to change tropism by forced passage through Fv-1 incompatible (Swiss/ICR) hosts. When this was done, CFV, originally N-tropic, became NB-tropic, and the leukemia induced by the virus spontaneously regressed. With one exception, all other FV's which induce a regressing leukemia are NB-tropic (27) (28) (29) . The apparent exception is a B-tropic virus inducing a leukemia that regresses (30) .
While our results show a strong relationship between tropism and the regressing phenotype, we suspect that altered tropism in itself is insufficient to endow an FV complex with this property. We have found that several passages of Ntropic CFV through BALB/c (Fv-1 ~') mice results in a change in tropism to NB without the incidence of significant leukemia regression. After a single passage of this virus stock in Fv-1 heterozygous Swiss/ICR mice, the leukemia induced by this virus consistently regresses.
We have observed that the change from induction of a nonregressing to regressing disease is acquired during passage in Swiss/ICR and is maintained on back passage in NIH/Swiss Fv-1" mice, reflecting a permanent change in the viral genome rather than a reversible modification in the virus. Changes in the virus genome which occur on mouse passage might be due to recombinational or reassortive events which occur in mice that possess certain gene loci (e.g., Fv-1~). The tropism requirement may reflect the ability of NB-tropic virus to initiate infection and growth in these cells, permitting subsequent modification.
Using virus mixtures we determined the effect of altering the content of helper virus in RFV on regression. For this purpose we selected Ri-MuLV which causes thymic lymphomas after a long latent period in newborn mice and which can substitute, in SFFV rescue, for the native helper MuLV in FV (15) .
The addition of excess Ri-MuLV to RFV inhibited leukemia regression. The inhibition of regression could be due to rescue of SFFV by Ri-MuLV. The consequence of this rescue would be the formation of at least two types of viruses, each with the same SFFV activity but with different MuLV helpers, i.e., SFFV-(MuLV-RF) and SFFV-(Ri-MuLV). If the Ri-MuLV pseudotype of SFFV predominated, then regression would not occur and its incidence would depend on the quantity of competing Ri-MuLV added to RFV. The results of the experiments shown in Table V demonstrate that increasing quantities of RiMuLV mixed with RFV cause a proportional decrease in the incidence of regression and a proportional increase in the incidence of leukemia. The latter observation suggests that Ri-MuLV rescued SFFV. Of interest is that Ri-MuLV and MuLV-RF are both NB-tropic. Competition by Ri-MuLV over MuLV-RF for SFFV, if successful, would not alter the virus tropism. The fact that regression was inhibited also suggests that NB-tropism itself is not sufficient to cause regression. Since immunosuppression inhibits regression (10) it is also possible that Ri-MuLV infection might severely disable those immune functions which play a major role in regression and thereby inhibit regression.
The helper MuLV isolated from RFV by end point dilution passage (MuLV-RF), when mixed with CFV, induced erythroleukemia that regressed, confirming the results of our earlier mixing experiments (11) . Further evidence for the determinative role of MuLV-RF in regression was obtained by examining the specificity of the effect of MuLV-RF on nonregressing leukemia using a variety of MuLV-F pseudotypes of SFFV and determining their ability to cause regression. Each of the rescued viruses caused spleen foci and erythroleukemia and therefore contained SFFV. Each of the viruses had acquired the tropism of the MuLV-F helper used in rescue, suggesting that these isolates were rescued by MuLV-F. It is possible that B to NB conversion was affected simply by passage of B tropic FV in Fv-1" mice and not by rescue. However, tropism conversion in a single rescue-passage method differs from the conventional multiple passage methods which result in B to NB conversion (17) . Inasmuch as there is no basis for expecting N to B or B to N conversion after a single passage, other than by rescue (17, 31), we conclude with some certainty that each of these viruses is a true host range pseudotype of SFFV. Immunological evidence of this can be obtained by determining whether each pseudotype has acquired the envelope antigens of the helper MuLV (31) . Since none of the helper MuLV's from FV contained SFFV activity by spleen focus assay before mixing with FV-B, nor could they cause erythroleukemia, the virus recovered from spleens of leukemic mice infected with each pseudotype possessed the same SFFV but different MuLV helper components.
The pseudotype composed of SFFV and MuLV-RF is NB-tropic and induces leukemia that spontaneously regresses. Rescue of the same SFFV by another NB-tropic MuLV-F, which had been derived by passage of N-tropic MuLV-F in BALB/c Fv-lb mice (R. J. Eckner, personal communication), also yielded NBtropic FV which caused leukemia that spontaneously regressed, but at a lower incidence. The conversion of FV-B to N tropism by rescue with MuLV-F derived from an N-tropic FV complex, yielded an N-tropic FV which induced erythroleukemia that did not regress. Since these studies were carried out in the same mouse strain, differences observed in the incidence of regression in mice infected with either of these viruses must be due to the particular helper MuLV of each SFFV pseudotype. The capacity of the MuLV-RF pseudotype to induce leukemia that regresses demonstrates that the regressing phenotype of RFV is due to MuLV-RF.
MuLV-RF itself causes lymphocytic leukemia after a long latent period in newborn mice. The characteristics of this disease will be detailed in a subsequent report which will demonstrate that the lymphocytic leukemia induced by MuLV-RF itself spontaneously regresses, further supporting the role of MuLV-RF as the (viral) determinant in regression of RFV erythroleukemia.
Summary
The RFV strain of the Friend virus complex induces an erythroleukemia that spontaneously regresses. The tropism of regressing Friend virus complex (RFV), which is conferred by its helper MuLV component, MuLV-RF, is different from that of the conventional virus strain, CFV. RFV is NB-tropic and CFV is Ntropic. Passage of nonregressing CFV through Fv-1 incompatible Swiss/ICR mice changed the tropism of CFV from N to NB and resulted in a virus strain which induced erythroleukemia that regressed. Passage of NB-tropic CFV back through Fv-1 compatible mice maintained NB-tropism and regression. Altering the quantity or type of helper MuLV in RFV complex by addition of Ri-MuLV inhibited regression in proportion to the amount of added Ri-MuLV. These studies indicate a relationship between a change in virus tropism to NB by passage in certain hosts (e.g., Swiss/ICR mice) and the ability of Friend virus to induce erythroleukemia that spontaneously regresses.
MuLV-RF isolated from the RFV complex induced lymphocytic leukemia in newborn mice which regressed and caused the regression of CFV-induced erythroleukemia. MuLV-RF is NB-tropic, contains no spleen focus-forming virus (SFFV) activity and helps SFFV form spleen foci in genetically restrictive mice. Pseudotype viruses were prepared, consisting of MuLV-RF, or other MuLV's, and SFFV derived from FV-B. The pseudotype viruses each acquired the tropism of the MuLV used in rescue. The pseudotype prepared with MuLV-RF or another NB-tropic MuLV-F, but not the virus obtained by rescue with N-tropic MuLV-F, induced erythroleukemia that spontaneously regressed. These studies demonstrate that the ability of RFV to induce erythroleukemia that spontaneously regresses is due to its helper MuLV component.
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